The Pre-clinical Services offered by Reliance comprises in vitro and in-vivo studies. These studies include efficacy and safety studies for cell-based therapies, Proteins, vaccines, chemical and medical devices entities. The facility located in Dhirubhai Ambani Life Sciences Centre, Navi Mumbai is GLP certified. GLP certification issued by NGCMA, DST, Government of India (dst.gov.in/ngcma), is in compliance with the OECD principles of GLP.

Salient features:

• State-of-the-art, barrier maintained facility with robust environmental monitoring system
• Class 10,000 animal rooms for immuno-deficient mice colonies
• OECD GLP compliant studies can be done for toxicology, mutagenicity, analytical and clinical chemistry testing
• Studies in Specific Pathogen Free animals
• Fully automated clinical and histopathology laboratory with highly skilled pathologists and technicians

Our experience and capabilities include:

In-vitro study	Bacterial reverse mutation assay (Ames test) In vitro micronucleus assay Chromosomal aberration assay Cytotoxicity assay Cell based efficacy assay
In-vivo study	Toxicity studies (Acute to chronic studies) Skin sensitization In vivo micronucleus assay Anti-cancer studies Animal based bioassay Generation of monoclonal and polyclonal antibody Creation of animal models of human diseases Pyrogen testing
Bio-analysis	Pharmacokinetics Toxicokinetics Estimation of antibodies
Quality control	Microbiological monitoring Genetic monitoring of laboratory animals
Animal Sale	Mouse Rat Guinea pigs Rabbit

Studies can be conducted as per required guidelines (eg. RCGM/ CDCSCO, OECD, ISO 10993, etc.)

Reliance LARS is registered with the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and conforms to its guidelines.